Biologics
End-to-end development services for cell and gene therapies, proteins and peptides, monoclonal antibodies, and antibody-drug conjugates
Integrated Biologics Development — From Cell Line to Clinic
MRIGlobal provides GMP-compliant biologics development across the full product lifecycle, from genetic engineering and cell line development through analytical characterization, formulation, and stability testing. Our scientists bring deep expertise in mammalian and bacterial expression systems, advanced analytical platforms including high-resolution mass spectrometry and next-generation sequencing, and a regulatory-focused approach that generates the data your IND submission requires. Whether you are developing a monoclonal antibody, an antibody-drug conjugate, a recombinant protein, or a cell or gene therapy, we provide the scientific depth and hands-on partnership to move your program forward.
Integrated Solutions for Biologics Development
Cell Line Development and Engineering
Develop and optimize your expression system using CRISPR-based gene editing, stable and transient expression platforms, and phenotypic and genotypic characterization — with master and working cell bank generation to support your clinical program.
Analytical Characterization and Method Qualification
Characterize your biologic with a full suite of analytical techniques, including identity and purity testing, cell-based and ligand-binding potency assays, protein sequence verification, PTM analysis, and method qualification to support your regulatory submissions.
Vector and Delivery System Evaluation
Support your cell and gene therapy program with viral vector QC and characterization, lipid nanoparticle and polymer-based delivery analytics, and gene editing efficiency and off-target analysis.
Pre-Formulation and Formulation Development
Develop robust, scalable formulations for your biologic through buffer optimization and excipient selection, solubility and aggregation studies, and compatibility testing designed to support manufacturability and shelf life.
Stability Testing
Establish your product’s storage conditions and shelf life with accelerated and real-time stability studies, ICH-compliant stability-indicating assays, and long-term storage condition optimization across temperature, pH, and freeze-thaw cycles.
Cell Banking and Repository Services
Establish and store qualified master and working cell banks with long-term cryogenic storage, full characterization documentation, and compound management services — helping ensure your biologics materials are secure, traceable, and accessible throughout development.
Latest from the blog
-
MRIGlobal’s SCALE Center is a major part of the $34 Million Tech Hubs Award that the EDA intends to provide to the KC BioHub Consortium
Kansas City’s newest chapter in a long tradition of world-changing science: bringing life-saving medicines closer to the patients who need them.
Biologics Pharmaceutical -
Improving Safety and Efficacy of CRISPR Drug Substances
CRISPR, short for Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing tool that has sparked excitement since its discovery in 2011. Since then, its contributions to agriculture, the discovery of emerging pathogens, and disease diagnostics and therapeutics have been immense. Recently, the first CRISPR edited cell therapy-based therapeutic was approved for treatment of […]
Biologics Pharmaceutical -
In Celebration of International Day of Women and Girls in Science
Sunday, February 11, marks the ninth International Day of Women and Girls in Science (IDWGS). Established in December 2015 by the United Nations General Assembly, the IDWGS aims “to recognize the critical role women and girls play in science and technology.” According to a UNESCO science report, globally, only one in three scientific researchers is […]
Biological Threats Biologics Field-Forward Pathogen Detection
